Julie Chen is a Director in Control Risks’ Compliance, Forensics and Intelligence practice in Hong Kong. She has specialised in forensic accounting, litigation support and insolvency for more than 11 years. Julie has been involved in FCPA compliance reviews and investigations in the Asia Pacific region, conducting interviews with key personnel, detailed investigations and transaction testing, identification of violations and advisory work.

Julie’s prominent engagements include:

• Conducted a five-month extensive investigation into the mainland China operations of a global multinational ATM manufacturer  following FCPA violations identified within its distribution network in Russia.
• Investigated whistle-blower and related corruption allegations regarding the China operations of a US and UK-listed pharmaceutical company, particularly transactions involving healthcare practitioners and travel agents used to facilitate improper payments.
• Investigated the mainland China operations of a world-leading manufacturer of scientific analytical instruments in response to allegations involving the State Food and Drug Administration of China.
• Investigated whistle-blower allegations involving corruption payments made through third-party partners on certain design/build projects in mainland China and Hong Kong of a global architectural and engineering firm.
• Involved in the administration and investigative aspects of hundreds of company liquidations, such as for a prominent surveying firm in Hong Kong and for a publicly listed company with approximately 100 subsidiaries.

Before joining Control Risks, Julie was a director of FTI Consulting’s forensic and litigation consulting practice based in Hong Kong. Prior to that, she was a manager of Baker Tilly Hong Kong’s business recovery and forensic accounting practice.

Julie is accredited as a Chartered Certified Accountant in the UK and a Certified Fraud Examiner. Julie received a BSc in mathematics from the University of Toronto, Canada. She speaks fluent English, Cantonese and native Mandarin.